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ABSTRACT 
 
Endoglin is a TGF- co-receptor expressed in endothelial cells, where it plays a crucial role in 
angiogenesis, cardiovascular development and vascular remodelling. In humans, mutations in 
the endoglin gene give rise to Hereditary Hemorrhagic Telangiectasia type 1 (HHT1), an 
autosomal dominant disorder associated with vascular lesions in skin, mucosa and internal 
organs. So far, endoglin cDNA has been sequenced in several species from mammals, 
amphibians and birds. While in mammals the characterization of endoglin protein expression 
and function is well documented, little is known about the protein homologue in birds. In 
silico analysis by multiple sequences alignment showed a low homology score of 30-33 
between the full length chicken endoglin protein and several mammalian homologues. 
However, a high homology score (80-85) was observed with the cytoplasmic and 
transmembrane regions and the overall structure of the zona pellucida (ZP) and orphan 
domains of the extracellular region appear to be conserved. Transient expression of chicken 
endoglin allowed the identification of a 180-kDa disulfide linked homodimer similar to the 
mammalian homologues. To further characterize its tissue expression, the novel specific 
monoclonal antibody (mAb) 7H5A8 was generated against chicken endoglin transfectant 
cells. The mAb 7H5A8 specifically recognized chicken endoglin by western blot, 
immunoprecipitation, immunofluorescence flow cytometry as well as immunofluorescence 
microscopy assays and displayed a positive staining of the endothelium in veins and arteries 
from frozen tissue sections of lung and bursa of Fabricius. These results may help to further 
understand the endoglin expression in vertebrates. 
 
 
 
 
Keywords: endoglin, zona pellucida, endothelium, antibody, TGF-beta 
 
 3 
1. Introduction 
Endoglin is an auxiliary TGF- receptor expressed in endothelial cells that plays a major role 
in cardiovascular development, as well as in angiogenesis and vascular remodeling and 
homeostasis (Lopez-Novoa & Bernabeu, 2010; Bernabeu et al., 2009; Lebrin & Mummery, 
2008). Mutations in the human ENDOGLIN gene (ENG) are responsible for the Hereditary 
Hemorrhagic Telangiectasia (HHT) type 1, a disease characterized by vascular malformations 
(McAllister et al., 1994). This pathological condition leads to frequent nose bleeds, 
telangiectases on skin and mucosa and may cause arteriovenous malformations in different 
organs including brain, lung, and liver (Shovlin et al., 2010). In addition to endothelial cells, 
endoglin can be expressed at lower levels in smooth muscle cells, activated macrophages and 
fibroblasts (Bernabeu et al., 2007). Endoglin expression is markedly upregulated in 
proliferating endothelial cells, where it plays a crucial role in angiogenesis during 
development and in adult animals (Li et al., 2001; Bernabeu et al., 2009; ten Dijke et al., 
2008; Lopez Novoa & Bernabeu, 2010). In fact, endoglin knockout mice die in utero because 
of defects in the vascular system (Arthur et al., 2000; Bourdeau et al., 1999; Li et al., 1999). 
While endoglin expression and function in mammals is widely documented, similar studies in 
birds are scarce. Chicken endoglin is expressed during heart development (Vincent et al. 
1998) and during pre-circulation vascular development, where it seems to play an important 
role in the transition from endothelial progenitors to functional endothelial cells (Alev et al., 
2010), and in post-circulation chick development, where endoglin is expressed 
intraembryonically in cardiac endothelium and in developing vessels (Mercado-Pimentel et 
al., 2007). Moreover, chicken endoglin is involved in angiogenesis (Raab et al. 1999) and in 
the process of epithelial-to-mesenchymal transformation during cardiac valve formation 
(Mercado-Pimentel et al., 2007).  
Endoglin cDNA has been sequenced in several species from mammals, amphibians and birds, 
including humans (Gougos and Letarte, 1990; Bellón et al. 1993), pig (Yamashita H et al. 
1994), rat (Meurer et al., 2005) and mouse (St-Jacques et al., 1994; Ge and Butcher, 1994). 
Human endoglin is expressed as a 180-kDa disulfide-linked homodimer (Gougos and Letarte 
1990) that contains a highly glycosylated extracellular domain of 561 amino acids. 
Structurally, endoglin belongs to the Zona Pellucida (ZP) family of proteins that share a ZP 
domain of ~260 amino acid residues at their extracellular region (Jovine et al. 2005; Llorca et 
al. 2007; Plaza et al., 2010). The three-dimensional structure of the extracellular domain of 
endoglin at 25Å resolution, using single-particle electron microscopy has been elucidated 
(Llorca et al. 2007). Endoglin is arranged as a dome made of antiparallel orientated monomers 
enclosing a cavity at one end. Each subunit comprises three well-defined regions, two of them 
corresponding to the ZP domain. The third region does not show any significant homology to 
other protein family/domain and thereby has been named the “orphan” domain. While in 
mammals the characterization of endoglin protein expression and function is well 
documented, similar studies in chicken remain to be performed. The knowledge about chicken 
endoglin sequence is of significant phylogenetic interest because chicken is the most distant 
species where an endoglin protein, with significant homology to the mammalian homologues, 
has been reported. Moreover, a widely used method to study angiogenesis is the chick embryo 
chorioallantoic membrane (CAM), which is very useful model in different fields of medicine, 
providing information on the timing of tissue changes before the establishment of adult 
vascularization (Ribatti, 2008). Because endoglin is an endothelial marker of neoangiogenesis 
(Lopez-Novoa & Bernabeu, 2010), the generation of chicken endoglin related reagents and 
tools may be very useful to further analyze the angiogenesis process. In silico analysis of the 
chicken endoglin cDNA sequence reported by us (AY702002) reveals an open reading frame 
coding for 644 amino acids with predicted domains for leader sequence, extracellular, 
transmembrane and cytoplasmic regions. In this paper we have made a comparative sequence 
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analysis between chicken endoglin and nine mammalian homologues and we have 
characterized the expression of recombinant endoglin protein in vitro. Moreover, we have 
generated a novel mAb against chicken endoglin that served to demonstrate the expression of 
endoglin in the endothelium from chicken tissue sections. 
 
2. Materials and Methods 
2.1. In silico analysis of chicken endoglin 
Multiple sequence alignment was performed using ClustalW2 (Larkin et al., 2007) at 
European Bioinformatic Institute web site (www.ebi.ai.uk). To predict the secondary 
structure, Jpred3 server (http://www.compbio.dundee.ac.uk/www-jpred/) at University of 
Dundee was used (Cole et al., 2008). MotifScan resource (http://myhits.isb-sib.ch/cgi-
bin/motif_scan) was used to predict conserved structural motifs (Pagni et al., 2007). N- and 
O-glycosylation predictions were performed using the NetNGlyc and NetOGlyc servers, 
respectively. Putative phosphorylation sites were predicted using NetPhos server (Blom et al., 
1999). All these tools are available at the Center for Biological Sequence Analysis (Technical 
University of Denmark) webpage (www.cbs.dtu.dk). 
2.2. Plasmids 
A 2,484-bp fragment of full length chicken endoglin cDNA (AY702002) was inserted into an 
EcoRI site of plasmid pcDNA3, resulting in the expression vector pcDNA3-ch.Eng. The wild 
type sequence in vector pcDNA3-ch.Eng was used to derive a hemagglutinin (HA)-tagged 
chicken endoglin expression vector. Specific oligonucleotides were used to prime the PCR 
synthesis of endoglin (amino acids 26–644) and the amplified 1,880-bp fragment was cloned 
into SfiI/SmaI sites of pDisplay (Invitrogen) vector. The resulting vector (pDisplay-HA-
ch.Eng) allows expression of the protein on the cell surface, using the leader sequence of the 
vector, and the mature protein contains an HA epitope at the NH2 terminus. Recombinant 
Newcastle disease virus from the lentogenic strain B1 (rNDV) expressing chicken (rNDV-
ch.Eng) or human (rNDV-h.Eng) endoglin have been described (Ayllon, 2009), and were 
rescued by reverse genetic techniques as reported (Nakaya et al., 2001) 
2.3. Cell culture and generation of cell transfectants 
The monkey epithelial kidney cells COS-7, the mouse fibroblast cell line L929, the African-
green monkey kidney cell line Vero and the white leghorn chicken B cell line DT40 were 
cultured in DMEM (COS-7, L929 and Vero) or RPMI-1640 (DT40) media (Gibco, Scotland, 
UK). All culture media were supplemented with 10% heat-inactivated fetal calf serum, 2 mM 
glutamine and 100 U/ml penicillin/streptomycin (complete media). Additionally, DT40 cells 
were supplemented with 1% of chicken serum and 50 M 2-mercaptoethanol. COS-7 cells 
were transiently transfected with expression vectors encoding chicken endoglin using 
SuperFect (Qiagen), as indicated by the manufacturer. The adherent mouse fibroblasts cell 
line L929, was used to generate stable transfectants expressing HA-tagged chicken endoglin, 
as described for human endoglin (Bellon et al., 1993). Briefly, cells were co-transfected in 
serum-free medium with pDisplay-HA-ch.Eng vector in the presence of DC-Cholesterol (3β-
[N-(N',N'-dimethylaminoethane) carbamoyl] cholesterol) and DOPE (dioleoyl-
phosphatidylethanolamine) (Sigma) at a 1:1 ratio, as transfection agent. Positive clones 
(L929-HA-ch.Eng) were selected in the presence of 400 mg/ml of the antibiotic Geneticin (G-
418 sulphate, Gibco). Pooled clones were used in biochemical characterizations and 
immunizations. Cell suspensions of the chicken B cell line DT40 were used to generate stable 
transfectants expressing HA-tagged chicken endoglin, as described for human endoglin 
(Lastres et al., 1996). DT40 cells were transfected with pDisplay-HA-ch.Eng by 
electroporation of 3x10
7
 cells in RPMI 1640 medium using a BTX 600 electroporator (350V, 
950 µF, 200Ω) with plasmid DNA in 2-mm cuvettes. After selection in RPMI medium 
containing 10% FCS and 2 mg/ml of Geneticin, endoglin-positive cells (DT40-HA-ch.Eng), 
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were sorted by immunofluorescence flow cytometry under sterile conditions. Pooled clones 
were used in biochemical studies. Cells were maintained in a NAPCO incubator at 37°C in a 
humidified atmosphere with 5% CO2.  
2.4. Generation of monoclonal antibodies to chicken endoglin 
Balb/c mice were immunized with murine L929-HA-ch.Eng cell transfectants expressing full-
length chicken endoglin tagged with an HA epitope at the N-terminus. Mice were 
intraperitoneally injected with 1 x 10
6
 L929-HA-ch.Eng cells in phosphate buffered saline 
(PBS), on days -45, -30 and -15. On day -3, mice were intravenously injected with 0.5 x 10
6
 
L929-HA-ch.Eng cells in PBS as a boost for the immunological response. On day 0, spleen 
cells were fused with SP2 mouse myeloma cells at a ratio of 4:1 (spleen cells:myeloma cells), 
using polyethylene glycol 1500 (Roche) and seeded in 96-well culture plates. After one week 
of growth in HAT (hypoxanthine, aminopterin and thymidine) (Sigma) selection medium, the 
reactivity of hybridoma supernatants was assayed by immunofluorescence flow cytometry 
using L929-HA-ch.Eng cells and using with anti-HA monoclonal antibodies (12CA5, Roche), 
as a positive control, and the hybridoma supernatant X63, as a negative control. Selected 
positive hybridomas were cloned by the limiting dilution method in 96-well plates. Among 
the positive hybridomas, the clone 7H5A8 producing an IgG1 antibody, was chosen for 
further characterization.  
2.5. Western blot, immunoprecipitation and biotinylation analyses 
For western blot and immunoprecipitation analyses, cells were lysed at 4ºC with Lysis Buffer: 
50 mM Hepes (Gibco), 150 mM NaCl, 0.5 mM EDTA, 0.1 mM EGTA, 1% Triton X-100, 10 
mM NaF, 1 mM Na3VO4 and protease inhibitors (Roche). Aliquots of total cell lysates, 
containing equivalent amounts of total protein, were precleared for 4 hours at 4ºC with 
protein-G Sepharose (GE Healthcare). Immunoprecipitations were carried out using specific 
antibodies coupled to protein-G Sepharose. After overnight incubation at 4ºC, 
immunoprecipitates were isolated by centrifugation and washed three times with lysis buffer. 
Total lysates and immunoprecipitates were separated by standard SDS-PAGE (6% 
polyacrylamide gel), under reducing or non-reducing conditions. When required, protein 
samples were dissolved in sample buffer containing 3M urea to fully denature the protein, 
prior to separation by SDS-PAGE, following the technical bulletin of the manufacturer 
(MWS-877X, Sigma). After SDS-PAGE, proteins were electrotransferred to a PVDF 
membrane (BioRad) for immunodetection with the indicated antibodies. Proteins were 
revealed by incubation with a rabbit polyclonal anti-mouse IgG/HRP (Dako), followed by 
incubation with SuperSignal chemiluminescent substrate (Pierce, Rockford, IL), according to 
the manufacturer´s instructions. Labelling of cell surface endoglin was carried out with EZ-
Link Sulfo NHS Biotin reagent (Pierce), as indicated by the manufacturer. Briefly, after 
washing the cells three times with cold PBS, they were incubated with the biotin reagent 
(diluted in PBS to 0.5 mg/ml) for 2 hours at 4ºC and with mild agitation. The reaction was 
stopped by washing 3 times with 100 mM glycine PBS. Finally, cells were lysed with Lysis 
Buffer as indicated above. Total cell lysates were immunoprecipitated with anti-HA mAb, 
7H5A8 mAb or a negative control antibody (X63). Immunoprecipitates were separated by 
SDS-PAGE and the presence of the recombinant chicken endoglin was revealed with 
streptavidin-peroxidase (PO) using a chemiluminescent substrate. 
2.6. Flow Cytometry 
Immunofluorescence flow cytometry was carried out as described (Guerrero-Esteo et al., 
1999). Briefly, cells were incubated with the primary antibodies 7H5A8 (anti-chicken 
endoglin), 12CA5 (anti-HA) or X63 (negative control) for 30 min at 4ºC. After two washes 
with PBS, cells were incubated with Alexa Fluor
R
 488 anti-mouse IgG (Invitrogen) at 4ºC for 
30 minutes. Finally, cells were washed twice with PBS and their fluorescence was estimated 
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with a FACSCalibur flow cytometer (BD Biosciences, Franklin Lakes, NJ, USA), using of 
logarithmic amplifiers.  
2.7. Immunohistochemistry (IHC) 
To assess the specificity of the mAb 7H5A8 for endoglin in endothelia, chicken frozen tissue 
sections with a high degree of vascularization (lung and bursa of Fabricius) were purchased 
(Gentaur, Belgium). Samples were processed for immunohistochemistry using the 
Novolink™ Min Polymer Detection System (Novocastra Laboratory, UK), according to the 
manufacturer´s instructions. Endogenous peroxidase and nonspecific staining were blocked 
by incubation with ready to use peroxidase-blocking and protein block solutions, respectively, 
followed by rinsing in Tris Buffered Saline solution 1X (TBS).  
The immunohistochemical method involved a sequential incubation with either the primary 
antibody to detect endoglin (mAb 7H5A8) or with the mAb X63 (negative control) for 45 
minutes. Then, samples were treated with a ready to use post primary block solution for 30 
minutes, followed by incubation with the NovoLink™ Polymer (rabbit anti-mouse IgG–Poly-
HRP) solution for 30 minutes. After a couple of rinses with TBS, immunoprecipitates were 
visualized by treatment with 3,3′-diaminobenzidine for 5 minutes and samples were 
counterstained with hematoxylin. Then, samples were dehydrated by quick steps in running 
water, ethanol 50%, ethanol 70%, ethanol 95%, ethanol 100% and xylene and slides were 
mounted with HI-MO mounting medium (Bio Optica, Milan, Italy). Samples were observed 
by light-microscopy (Zeiss, Axiovert 25) and the photos were taken using an Olympus E-330 
camera.  
2.8. Immunofluorescence and confocal microscopy 
Immunofluorescence was performed on both frozen tissue sections and adherent cultured 
cells, using the same procedure. Samples were fixed with formaldehyde (3.5%) at 4ºC for 5 
minutes, rinsed with PBS and incubated with the primary antibodies 7H5A8 hybridoma 
supernatants, X63 hybridoma supernatant, mAb anti-HA and mAb QH1 for 1 hour at 4ºC. 
The mAb QH1 recognizes an endothelial marker in quail and was purchased from DSHB 
(University of Iowa, USA). Samples were rinsed twice with PBS and then incubated with the 
secondary antibody Alexa Fluor® 488 anti-mouse IgG (Invitrogen, Molecular Probes, 
Eugene, Oregon, USA) diluted 1:100 in BSA 1% for 1 hour at 4ºC. After two washes with 
PBS, samples were incubated with DAPI 1µg/ml and Alexa Fluor 546 Phalloidin 5U/ml 
(Molecular Probes, Eugene, Oregon, USA) and subsequently mounted using ProLong Gold 
antifade reagent (Invitrogen, Molecular Probes, Eugene, Oregon, USA). Samples were 
observed using a fluorescence microscope (Zeiss Axioplan Universal Microscope) equipped 
with CCD camera (Digital Camera Leica DFC 350 FX and computer Power Mac G4 OS X) 
and by spectral confocal microscopy (TCS SP2, Leica Microsystems, Nussloch, Germany). 
 
3. Results 
3.1. In silico analysis of chicken endoglin protein 
A comparative analysis of the chicken endoglin protein and 9 different mammalian species 
was carried out using the alignment program ClustalW2 (Fig. S1). Overall, a low homology 
score (<33) between the full length chicken protein and the mammalian homologues was 
found (Table 1). This is compatible with the distant position of chicken endoglin in a 
comparative phylogenetic tree (Fig. S2). By contrast, a high homology score (80-85) was 
observed with the cytoplasmic and transmembrane regions (Table 2). This high degree of 
conservation suggests that the cytoplasmic region should play an important common role in 
cellular functions among distinct species. In addition, the overall structure of the zona 
pellucida (ZP) domain of the extracellular region appears to be conserved (Fig. S1). Indeed, a 
conserved ZP structural domain from residues K354 to G548 (raw score: -12.7; N-score: 
13.619; E-value: 5.1x10
-7
) was predicted using the MotifScan server, in agreement with the 
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ZP domain previously described in human endoglin (Llorca et al., 2007). Moreover, the 
secondary structure of chicken endoglin was predicted as a beta-strand enriched protein using 
the Jpred3 server, which fits well with the overall structure of endoglin and the putative ZP 
domain in particular (Llorca et al., 2007). Nevertheless, this structural domain in chicken 
endoglin contains only 6, instead of the 8 cysteine residues that characterize the mammalian 
ZP domains (Llorca et al., 2007; Jovine et al., 2005; Plaza et al., 2010). Furthermore, only 4 
out of those 6 cysteine residues are conserved in other species (Fig. S1). On the other hand, 
the N-terminal region of chicken endoglin does not show any structural homology domain, so 
it was designated as orphan domain (OD), as reported for the human endoglin (Llorca et al., 
2007). It is worth noting the low homology score obtained for the alignment when comparing 
the OD and ZP domains in chicken versus the nine mammalian species analyzed (best score 
for OD ≤ 30; best score for ZP ≤ 25). Because mammalian endoglin has been shown to be O- 
and N-glycosylated (Gougos and Letarte, 1990), the potential glycosylation sites of chicken 
endoglin were analyzed in silico. Thus, NetNGlyc server showed a 7 matching pattern for N-
glycosylation at Asn residues, all of them in the extracellular region (positions 79, 249, 258, 
299, 377, 390 and 551). In addition, the NetOGlyc server showed a unique Thr residue at 
position 333, as susceptible of being O-glycosylated. However, we should take into account 
that these bioinformatic tools are designed to predict glycosylation sites using matrices or 
consensus motifs based on mammalian proteins, so the results with chicken endoglin should 
be taken only as a hint. Moreover, the NetPhos server predicted 8 residues in the cytoplasmic 
tail that are prone to be phosphorylated, including 6 Ser residues (positions 609, 615, 621, 
624, 625 and 629) and 2 Thr residues (616 and 636). This is in agreement with the Ser/Thr 
phosphorylation observed in human and porcine endoglin (Lastres et al., 1994; Yamashita et 
al., 1994; Koleva et al., 2006).  
3.2. Expression of chicken endoglin in mammalian and chicken cell lines  
Because of the lack of a reliable source of antibodies to chicken endoglin (Raab et al., 1999), 
its detection remains a challenge. In order to bypass this restriction, an expression vector 
encoding HA-tagged chicken endoglin (pDisplay-HA-ch.Eng) was generated, as described in 
Materials and Methods. Thus, expression of this recombinant protein would allow its 
detection by using commercially available anti-HA antibodies. Indeed, Western blot analysis 
of monkey COS-7 cells transiently transfected with pDisplay-HA-ch.Eng demonstrated the 
presence of ~90-kDa protein under reducing conditions that corresponds to the expected 
monomeric primary structure (Fig. 1A). The analysis under non-reducing conditions reveals 
the presence of an oligomeric structure as well as the monomer. Similar results were obtained 
when analyzing stable murine cell transfectants expressing HA-tagged chicken endoglin (Fig. 
1B). Interestingly, in these two mammalian cell types, the size of the oligomer was much 
higher than the one expected for the interchain disulfide dimer of endoglin (~180kDa). This 
oligomerization effect was also detected in DT40 chicken cells stably expressing HA-tagged 
chicken endoglin, excluding a mammalian specific effect (Fig. 1C). Because endoglin 
contains a ZP domain that is well known to enhance the oligomerization capacity of proteins 
(Jovine et al., 2002; Plaza et al., 2010), we hypothesized that these oligomers are formed by 
non-covalent interactions of the proteins. In order to eliminate these non-covalent 
interactions, we carried out a denaturing SDS-PAGE analysis in the presence of urea. Under 
these conditions, the western blot analysis revealed the expected size for the monomer and the 
disulfide-linked dimer of chicken endoglin in two different mammalian cell types (Fig. 1D). 
As a control, the size of human endoglin was shown to be similar to that of the chicken 
homologue. 
To assess whether chicken endoglin was expressed on the cell surface, two types of 
experiments were carried out. First, immunofluorescence flow cytometry analyses 
demonstrated that ectopically expressed recombinant chicken endoglin was recognized by 
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anti-HA antibodies on the surface of stable transfectants in chicken and murine cells (Fig. 
2A). Second, stable transfectants expressing HA-tagged chicken endoglin were subjected to 
cell surface biotinylation, followed by immunoprecipitation with anti-HA antibodies. As 
shown in Fig. 2B, recombinant chicken endoglin was clearly detected in the specific 
immunoprecipitates in monomeric and oligomeric forms. These data suggest that chicken 
endoglin is expressed at the cell surface as previously described for human endoglin. 
3.3. Generation and characterization of the mAb 7H5A8 specific for chicken endoglin. 
To generate antibodies to chicken endoglin, mice were immunized with the murine L929-HA-
ch.Eng cell transfectants expressing full-length chicken endoglin tagged with an HA epitope 
at the N-terminus. The characterization of these transfectants has been documented in Figs. 
1B and 2A. By using a murine background in the cells injected as antigen, the immune 
response was expected to be focused against the xenogeneic chicken endoglin. Hybridoma 
supernatants were screened for the presence of specific antibodies against chicken DT40 
stable transfectants expressing recombinant chicken endoglin (see Figs. 1C and 2B) by 
immunofluorescence flow cytometry. This screening yielded mAb 7H5A8 as specific for 
chicken endoglin. This is illustrated in Fig. 3A by the strong reactivity of the mAb 7H5A8 for 
the DT40 stable transfectants expressing recombinant chicken endoglin and by the lack of 
reactivity against parental cells. This result suggests that the mAb 7H5A8 recognizes an 
antigenic epitope on the extracellular domain of chicken endoglin. As a positive control, cell 
surface endoglin was also stained with anti-HA mAb. Western blot analysis also 
demonstrated the specific reactivity of the mAb 7H5A8 for chicken endoglin when the 
electrophoretic separation was carried out under non-reducing conditions (Fig. 3B). By 
contrast, the mAb 7H5A8 showed a weak reactivity against the monomeric endoglin when the 
electrophoresis was carried out under reducing conditions. A parallel control experiment with 
anti-HA antibodies evidenced the strong reactivity of these antibodies against monomeric and 
oligomeric endoglin. In addition, the mAb 7H5A8 was able to recognize both wild type and 
HA-tagged chicken endoglin by immunoprecipitation experiments (Fig. 3C), ruling out the 
possibility that the mAb 7H5A8 might be specific for the HA tag.  
Next, the binding of the mAb 7H5A8 to recombinant chicken endoglin expressed on cultured 
cell lines was assessed by immunofluorescence microscopy. As shown in Fig. 4, monkey 
COS-7 cells transiently transfected with chicken endoglin (Fig. 4A), monkey Vero cells 
infected with recombinant Newcastle disease virus expressing chicken endoglin (Fig. 4B) and 
murine L929 fibroblasts stably transfected with chicken endoglin (Fig. 4C) showed a positive 
fluorescent staining with the mAb 7H5A8. The staining of mAb 7H5A8 was found 
predominantly on the cell surface, in agreement with the membrane localization of endoglin. 
Finally, the reactivity of the mAb 7H5A8 was tested in chicken frozen tissue sections of lung 
and Bursa of Fabricius, two organs that are highly vascularized. Immunohistochemistry of 
lung and bursa sections demonstrated the positive staining of mAb 7H5A8 in vessels (Fig. 
5A). Immunofluorescence microscopy experiments also showed a clear staining of veins and 
arteries in bursa samples counterstained with phalloidin and DAPI (Fig. 5B). Analysis at a 
higher magnification showed a positive staining with the mAb 7H5A8 in the tunica intima of 
bursa arteries (Fig. 5C). This localization of chicken endoglin is in agreement with the 
endothelial expression reported for mammalian endoglin. In the same experiment, staining 
with the mAb QH1, specific for avian vessels, was included as a positive control. Moreover, 
staining experiments with mAb 7H5A8 in formaldehyde-fixed paraffin embedded chicken 
tissues did not yield positive results (data not shown), suggesting that the mAb 7H5A8 
recognizes an epitope on the endoglin protein in a native state, but is unreactive against the 
denatured protein. 
 
 
 9 
4. Discussion 
Endoglin is expressed in endothelial cells, where it plays a crucial role in angiogenesis, 
cardiovascular development and vascular remodeling (Lopez-Novoa & Bernabeu, 2010; ten 
Dijke et al., 2008; Lebrin & Mummery, 2008; Raab et al., 1999). While in mammals the 
characterization of endoglin protein expression and function has been widely studied, little is 
known about the avian homologue. Here, we have analyzed for the first time the protein 
sequence and the ectopic expression of chicken endoglin. A high degree of identity between 
chick and mammalian endoglins was found at the transmembrane and short cytoplasmatic tail 
domains. Remarkably, 100% conservation was detected in the C-terminal 24 amino acids, 
containing a PDZ-binding motif as well as target residues that are known to be 
phosphorylated in mammalian endoglin by TRII, ALK1 and ALK5 (Guerrero-Esteo et al., 
2002; Yamashita et al., 1994; Lastres et al., 1994; Koleva et al. 2006; Ray et al., 2010). This 
high conservation degree suggests that the cytoplasmic region plays a common functional role 
among different species. In this regard, the endoglin cytoplasmic domain has been postulated 
to modulate the TGF-β cellular responses through its interaction with, and phosphorylation 
by, the TGF-β signaling receptors (Bernabeu et al., 2007). Of note, endoglin phosphorylation 
influences its subcellular localization and deletion of the putative C-terminal PDZ-binding 
motif results in endoglin hyperphosphorylation of distal threonine residues (Koleva et al., 
2006). These data reveal that kinase-mediated phosphorylation of endoglin is a complex 
process involving a negative regulation by the PDZ-binding motif. Another level of regulation 
may be provided by the interaction of the endoglin cytoplasmic domain with other cytosolic 
proteins as described in humans. This is the case of zyxin and zyxin-related protein 1 (ZRP-1) 
involved in actin organization and assembly around focal adhesions (Conley et al., 2004; 
Sanz-Rodriguez et al., 2004), Tctex2b, a member of the Tctex1/2 family of cytosolic dynein 
light chains, linking endoglin to the microtubule based transport machinery (Meng et al., 
2006) or beta-arrestin2 involved in endoglin internalization in endocytic vesicles (Lee and 
Blobe, 2007). It will be interesting to investigate whether these mammalian endoglin binding 
proteins also have homologues that interact with chicken endoglin. 
In silico analysis of chicken endoglin also revealed the existence of a conserved ZP structural 
domain (residues K354 to G548). This consensus ZP domain is present in a large family of 
proteins and is potentially involved in endoglin receptor oligomerization (Jovine et al., 2005; 
Llorca et al., 2007). Supporting this view, analysis by standard SDS-PAGE under non-
reducing conditions revealed the presence of endoglin oligomers with a molecular weight 
higher than the expected size of the disulfide linked homodimer (Fig. 1C). This 
oligomerization effect is likely due to the contribution of non-covalent interactions mediated 
by the ZP domains. Indeed, these oligomeric interactions were inhibited under strong 
denaturing conditions in the presence of urea (Fig. 1D).  
The N-terminal region of chicken endoglin (H26-S351) showed a relatively low homology 
with the other vertebrate homologues. This region corresponds to the orphan domain, which 
has been structurally characterized in human endoglin (Llorca et al., 2007). It has been 
postulated that this domain is responsible for binding to the TGF-β superfamily members in 
humans, including TGF-β1, TGF-β3, activin, BMP7 or BMP9 (Lopez-Novoa & Bernabeu. 
2010). However, preliminary experiments in our laboratory failed to demonstrate functional 
binding of human TGF-1 to chicken endoglin. The homologous avian ligands that bind to 
chicken endoglin remain to be identified. 
Expression studies of recombinant chicken endoglin demonstrated that it is a 180-kDa 
disulfide-linked homodimer that is expressed at the cell surface (Figs. 1 and 2). Generation of 
stable cell transfectants allowed the production of the mAb 7H5A8 against chicken endoglin. 
Previous studies used polyclonal or monoclonal antibodies with mammalian specificities that 
crossreacted with chicken endoglin, yielding a specific, although weak reactivity (Luque et 
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al., 1997; Raab et al., 1999). This is the first time that a mAb is described against chicken 
endoglin using chicken endoglin as an antigen and it will be a useful tool to further advance in 
the knowledge of this protein and its role in vascular biology. The mAb 7H5A8 specifically 
recognized chicken endoglin in immunoprecipitation, immunofluorescence flow cytometry, 
immunohistochemistry and immunofluorescence microscopy studies. The optimal binding of 
the mAb 7H5A8 was obtained when the chicken endoglin protein was in a native structure. 
By contrast, weak or null recognition was obtained in our hands when the protein was 
denatured as it was the case of Western blot upon SDS-PAGE under reducing conditions or 
staining of formaldehyde paraffin embedded tissues. One of the interesting results from the 
immunohistochemistry and immunofluorescence microscopy experiments is that the mAb 
7H5A8 recognizes chicken endoglin in the endothelia from veins and arteries, a finding that is 
in line with the localization of endoglin in human vascular endothelium (Lopez-Novoa & 
Bernabeu, 2010; Mahmoud et al. 2009). Furthermore, whole-mount in situ hybridization 
studies on chicken embryos demonstrated expression of endoglin during embryonic pre-
circulation stages mainly confined to areas of vasculogenesis, being strongest in endothelial 
cells undergoing active vascularization and lower or undetectable in differentiated vessels 
(Alev et al., 2010). Moreover, using the chick chorioallantoic membrane as an angiogenic 
model, the involvement of chicken endoglin in angiogenesis was demonstrated (Raab et al., 
1999).  
The important role that endoglin plays in endothelial biology and its predominant expression 
in this cell lineage suggests a close association with the phylogenetic origin of endothelial 
cells. Supporting this hypothesis, the endoglin family is expressed in vertebrates, but not in 
invertebrates and the main difference between invertebrate and vertebrate vascular system is 
the presence of a true endothelium. So far, there is no consensus phylogenetic theory to 
explain the origin of the endothelial cells in vertebrates or a comprehensive approach to the 
transition between the vertebrate and the invertebrate types of circulatory system (Muñoz-
Chapuli et al. 2005). The study of endothelial genes and their encoded proteins such as 
endoglin may help to understand the complex phylogenetic transition to the vascular 
endothelial system in vertebrates. 
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FIGURE LEGENDS 
 
Figure 1. Expression of chicken endoglin in mammalian and chicken cell lines. A. COS-7 
cells were transiently transfected with the expression vector encoding HA-tagged chicken 
endoglin, pDisplay-HA-ch.Eng (HA-ch.Eng) or the pDisplay empty vector (Control). Proteins 
from total cell lysates were separated by SDS-PAGE followed by western blot analysis. 
Chicken endoglin was detected with an anti-HA mAb. B. Stable murine L929 fibroblast 
transfectants expressing HA-tagged chicken endoglin (HA-ch.Eng) and parental L929 cells 
(Control) were lysed and immunoprecipitated with anti-HA antibodies. Total cell lysates (left 
panel) or immunoprecipitates (right panel) were separated by SDS-PAGE, followed by 
western blot analysis using anti-HA mAb. C. Stable chicken DT40 cell transfectants 
expressing HA-tagged chicken endoglin (HA-ch.Eng) and parental DT40 cells (Control) were 
lysed. As a mammalian control, COS-7 cells transiently transfected, as described in panel A, 
were included. Total cell lysates were separated by SDS-PAGE followed by western blot 
analysis using anti-HA mAb. D. Stable L929 fibroblasts transfectants expressing HA-tagged 
chicken endoglin (HA-ch.Eng) and COS-7 cells transiently transfected with HA-tagged 
chicken endoglin (HA-ch.Eng) or HA-tagged human endoglin (HA-h.Eng) were lysed with 
sample buffer containing 3M urea to fully denature the proteins. Total cell lysates were 
separated by SDS-PAGE under denaturing conditions as described in Materials and Methods. 
Western blot analysis was performed using anti-HA mAb. Asterisks indicate the presence of 
unspecific bands. Proteins were separated by SDS-PAGE under either reducing (R) or non 
reducing (NR) conditions, as indicated. 
 
Figure 2. Detection of chicken endoglin on the cell surface. A. Flow cytometry analysis. 
Stable chicken DT40 cell transfectants and stable murine L929 fibroblast transfectants 
expressing HA-tagged chicken endoglin (HA-ch.Eng) as well as the corresponding parental 
cells were analyzed by immunofluorescence flow cytometry with anti-HA antibodies. The 
percentage of positive cells is indicated by the lower horizontal bar. B. Stable chicken DT40 
cell transfectants expressing HA-tagged chicken endoglin (HA-ch.Eng) and parental DT40 
cells were biotinylated on the cell surface and lysed. Total cell lysates were 
immunoprecipitated with an anti-HA antibody (-HA) or a negative control antibody (cAb). 
Immunoprecipitates were separated by SDS-PAGE and the presence of the recombinant 
chicken endoglin was revealed with streptavidin-peroxidase (PO). Asterisks indicate the 
presence of unspecific bands. Proteins were separated by SDS-PAGE under either reducing 
(R) or non reducing (NR) conditions, as indicated. 
 
Figure 3. Reactivity of the mAb 7H5A8 for recombinant chicken endoglin. A. Flow 
cytometry analysis. Stable chicken DT40 cell transfectants expressing HA-tagged chicken 
endoglin (HA-ch.Eng-DT40) and the corresponding parental DT40 cells were analyzed by 
immunofluorescence flow cytometry with 7H5A8 and anti-HA mAb; a negative control 
antibody (cAb) was also included. The percentage of positive cells is indicated by the lower 
horizontal bar. B. Western blot analysis. Stable chicken DT40 cell transfectants expressing 
HA-tagged chicken endoglin (HA-ch.Eng) were lysed. Total cell lysates were separated by 
SDS-PAGE followed by western blot analysis using 7H5A8 and anti-HA mAbs. C. 
Biotinylation studies on cells expressing HA-tagged and untagged chicken endoglin. COS-7 
cells were transiently transfected with expression vectors encoding either HA-tagged chicken 
endoglin, (HA-ch.Eng) or wild type untagged chicken endoglin (ch.Eng). Cells were 
biotinylated on the cell surface and lysed. Total cell lysates were immunoprecipitated with 
7H5A8 mAb or a negative control antibody (cAb), as indicated. Immunoprecipitates were 
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separated by SDS-PAGE and the presence of the recombinant chicken endoglin was revealed 
with streptavidin-peroxidase (PO). 
 
Figure 4. Immunofluorescence of cells transduced with chicken endoglin using the mAb 
7H5A8. A. COS-7 cells were transiently transfected (ch.Eng) or not (control) with untagged 
chicken endoglin for 24 hrs. Cells were stained with DAPI to visualize the nuclei (blue stain), 
with phalloidin to visualize the actin filaments (red stain) and with the mAb 7H5A8 coupled 
to an Alexa 488-labelled secondary antibody (green fluorescence), as indicated. Overlapping 
of the three colours is shown in the last row (Merge). Images were captured by confocal 
microscopy at X400 magnification. B. Vero cells were infected with either a recombinant 
Newcastle disease virus expressing chicken endoglin (rNDV-ch.Eng), a recombinant 
Newcastle virus expressing human endoglin (rNDV-h.Eng) or a negative control Newcastle 
virus (Mock). Cells were stained with the mAb 7H5A8 coupled to FITC-labelled secondary 
antibody (green fluorescence). Images were captured at X100 (upper panels) or X600 (lower 
panels) magnification. C. Stable L929 fibroblast transfectants expressing HA-ch.Eng or 
parental cells were stained with DAPI to visualize the nuclei (blue stain) and with the mAb 
7H5A8 coupled to an Alexa 488-labelled secondary antibody (green fluorescence), as 
indicated. Overlapping of the two colours is shown in the last row (Merge). Images were 
captured at X200 magnification. 
 
Figure 5. Staining of chicken tissues with the mAb 7H5A8. A. Immunohistochemistry on 
frozen chicken sections of Bursa of Fabricius and lung. Samples were stained with the mAb 
7H5A8 or a negative control mAb (X63) followed by incubation with peroxidase-coupled 
rabbit anti-mouse IgG. The primary antibody was visualized by incubation with 3,3′-
diaminobenzidine. Samples were counterstained with hematoxylin and photographs were 
taken by light microscopy at the indicated magnification. B. Immunofluorescence on frozen 
chicken sections of Bursa of Fabricius. Samples were stained with DAPI to visualize the 
nuclei (blue stain), the mAb 7H5A8 coupled to an Alexa 488-labelled secondary antibody 
(green fluorescence) and phalloidin to visualize actin filaments (red stain), as indicated. As a 
negative control, samples were stained with the mAb X63 (bottom row). Overlapping of the 
three colours is shown in the last column (Merge). The pictures were taken at an original 
magnification of X400. C. Immunofluorescence on frozen chicken sections of Bursa of 
Fabricius and lung. Samples were stained with DAPI to visualize the nuclei (blue stain), 
phalloidin to visualize actin filaments (red stain) and the mAb 7H5A8 coupled to an Alexa 
488-labelled secondary antibody (green fluorescence), as indicated. As a negative control, 
Bursa sections were stained with mAb X63 (Cont-Ab). As positive controls, lung and Bursa 
sections were stained with the vascular endothelium specific mAb QH1. Photographs were 
taken at an original magnification of X400 or X600, as indicated. 
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Organism 1 Length (aa) Organism 2 Length (aa) Score
Chicken 644 Cow 647 33
Chicken 644 Dog 721 33
Chicken 644 Human 658 33
Chicken 644 Orangutan 672 32
Chicken 644 Opossum 673 31
Chicken 644 Marmoset 692 30
Chicken 644 Mouse 653 30
Chicken 644 Pig 653 30
Chicken 644 Rat 650 30
Table 1.  Sequence homology analysis of full length chicken endoglin* 
*The alignment score is indicated in the right column
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Organism 1 Length (aa) Organism 2 Length (aa) Score
Chicken 70 Opossum 70 85
Chicken 70 Orangutan 72 82
Chicken 70 Human 72 82
Chicken 70 Dog 72 82
Chicken 70 Mouse 72 81
Chicken 70 Rat 72 81
Chicken 70 Cow 72 81
Chicken 70 Marmoset 72 81
Chicken 70 Pig 72 80
Table 2.  Sequence homology analysis of transmembrane and 
cytoplasmic domains of chicken endoglin* 
*The alignment score is indicated in the right column
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